Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon.
about
Chronic viral hepatitis C: management updateChronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alphaPatients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 moleculesBeta interferon therapy for chronic hepatitis C in patients with haemophilia and other haemorrhagic disorders.Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinomaEffects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection.Initial results with recombinant interferon alfa-2b in patients with chronic hepatitis C: the United States experience.A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infectionClinical characterization of a competitive PCR assay for quantitative testing of hepatitis C virus.Hepatitis C: progress and problems.Quantitation of hepatitis C viral RNA in liver and serum samples using competitive polymerase chain reaction.Hepatitis C: Recent advances.The long-term efficacy of interferon alfa in chronic hepatitis C patients: a critical review.Autoantibodies before, during and after administration of recombinant interferon-alpha for chronic viral hepatitis.Hepatitis C virus infection. Treatment with interferon reduces viraemia.Long-term administration of natural interferon-alpha in patients with chronic hepatitis C: relationship to serum RNA concentration, HCV-RNA genotypes, histological changes and hepatitis C virus.Hepatic HCV-RNA as a predictor of outcome after interferon therapy in patients with chronic hepatitis C.Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus.The effects of a high dose, short course of interferon on hepatitis C.Fluctuations of hepatitis C virus load are not related to amino acid substitutions in hypervariable region 1 and interferon sensitivity determining region.Long-term administration of interferon-alpha in non-responder patients with chronic hepatitis C: follow-up of liver fibrosis over 5 years.Clinical characteristics of patients with chronic hepatitis C showing biochemical remission, without hepatitis C virus eradication, as a result of interferon therapy. The Osaka Liver Disease Study Group.Treatment of chronic hepatitis C with interferon-alpha: sustained absence of hepatitis C virus RNA from serum after four courses of therapy.Interferon treatment of hepatitis C: is it virological cure?Maturation of dendritic cells with lipopeptides that represent vaccine candidates for hepatitis C virus.Two dose regimens of recombinant interferon-alpha-2b in chronic hepatitis C virus infection. Biochemistry, hepatitis C virus RNA, and liver histology as response indices.Hepatitis in alcohol and drug misusers: practical issues.Influence of previous interferon therapy on recurrence after resection of hepatitis c virus-related hepatocellular carcinoma.Quantitative analysis of interferon alpha/beta receptor mRNA in the liver of patients with chronic hepatitis C: correlation with serum hepatitis C virus-RNA levels and response to treatment with interferon.Hepatitis C virus infection and interferon therapy in patients with Down syndrome.Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma.Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma
P2860
Q27471844-8F6B8682-CAD0-4D06-A1F3-5291A37DACCFQ27473012-3E672870-6F86-4C89-A351-B351059BEB25Q27478466-EC2DB378-F7A4-4383-B0F7-8147FBD42720Q33432442-A92D24D0-4F49-4240-887D-3696242619B8Q34225588-C66CC324-649D-4C06-8709-435CED928C25Q34294938-32152DA9-4D47-46E5-919D-7C3D13EEAEC9Q34375826-A6A1C67C-428D-4CD4-BAC6-9E2B0B7377F6Q35920476-EE509D2D-B592-4C8F-B562-A59F5AEE825AQ36537170-5E060D47-3460-47F5-BF5C-83A01299A9C2Q36642065-E33847E8-4B43-4819-BDCE-BFC3B0B50A74Q39654836-37702612-9AF2-4B2C-B304-F9715B1099A3Q40142234-E47B02B3-60F1-4D62-B603-01D8F1F4C44DQ40957762-E0566809-2321-4633-AEBE-5CD040E6B7F4Q41054344-CE2D1D95-1604-49FE-8F61-09ED92BD0284Q42588257-0F6DE186-47C5-497B-A10B-57D7F05B1764Q42977407-1A5401A3-D2A6-49AE-BFB2-B44D195C02A5Q42978095-43275F0B-97AD-4E80-BEDC-CDCDD7D2DB0FQ42981208-73A0EC81-C00C-4706-AF46-400AD14C9CB8Q42992189-BDB547C9-428A-40CA-8CBD-F08181EE2089Q42994719-6F239D4C-26B8-41AE-80D1-625A6EB4DE6DQ42996535-170C89EF-1034-4BB1-8718-D3E0014F87B9Q43000078-21DB7CC1-6F54-4829-A0F1-7E087518A0FDQ43037662-7D968BC5-090D-45A9-815F-15182684E833Q43038924-3957C50E-F9DF-4CB8-82AD-B55E02CC4B8DQ43041894-0C0ED300-3354-4E00-83B7-47672E1B1FC3Q43047084-9C976C91-6E7B-4479-AF12-1BEA0628209BQ44377173-B2CE596F-CAED-41F5-AB0E-B373D33159A5Q45738745-CE97092F-A583-4E27-97DE-3DB4A6DC614FQ45762371-C6DA3471-0D59-48DD-B023-01150832C861Q54683078-C2DA1AC9-BB63-4BFD-9D82-7DCD21C160F8Q55094662-D6C6F0E5-02CF-4276-8E91-8FD8C931C743Q57763097-ED71C5CC-AE41-4192-AB94-EB431AAC6C0C
P2860
Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon.
@en
Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon.
@nl
type
label
Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon.
@en
Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon.
@nl
prefLabel
Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon.
@en
Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon.
@nl
P2093
P356
P1433
P1476
Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon.
@en
P2093
A M Di Bisceglie
J H Hoofnagle
P2860
P304
P356
10.1002/HEP.1840150607
P407
P577
1992-06-01T00:00:00Z